Article
Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation.
Endocrine-related cancer - 1 May 2016
Corman Vinciane, Potorac Iulia, Manto Florence, Dassy Sarah, Segers Karin, Thiry Albert, Bours Vincent, Daly Adrian F, Beckers Albert
Abstract excerpt
Breast cancer is rare in male patients. Certain predisposing factors, be they genetic (e.g., BRCA2 gene mutations) or hormonal (imbalance between estrogen and androgen levels), have been implicated in male breast cancer pathophysiology. Male-to-female (MtF) transsexualism is a condition that generally involves cross-sex hormone therapy. Anti-androgens and estrogens are used to mimic the female hormonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
